Literature DB >> 7687386

Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat.

E H Lee1, C P Lee, H I Wang, W R Lin.   

Abstract

In the present study, we investigated the neural mechanisms of corticotropin-releasing factor (CRF) and the interactions among CRF, norepinephrine (NE), and N-methyl-D-aspartate (NMDA) systems in the dentate gyrus (DG) of hippocampus in modulating the memory process of rats. One-way passive avoidance task was adopted. Results indicated that CRF (80 ng), when directly injected into the DG, consistently and significantly enhanced memory retention in rats. The noradrenergic neurotoxin DSP-4, at a high dose (4 micrograms), impaired memory. DSP-4 at a moderate dose (2 micrograms), which did not affect retention alone, antagonized the memory-enhancing effect of CRF. Similarly, the beta-adrenergic antagonist propranolol, at a high dose (8 micrograms), reduced retention. At a low dose (80 ng), which did not markedly affect retention by itself, propranolol also prevented the memory-improving effect of CRF. Moreover, direct NE infusions to the DG significantly improved retention performance in a dose-sensitive manner. Coadministration of CRF and NE did not further enhance retention. These results together suggest that CRF and NE facilitated memory probably through the same instead of independent mechanisms. In contrast, the selective NMDA receptor antagonists 2-amino-5-phosphonopentanoate (AP5) and MK801, at high doses markedly impaired memory retention (0.8 and 3.2 micrograms for AP5, 2 and 10 micrograms for MK801). At a dose of MK801 that did not significantly alter retention alone (80 ng), it completely blocked the memory-facilitating effect of CRF. These results indicate that CRF enhanced memory indirectly through NMDA receptor mediation also. Finally, MK801 at 80 ng also successfully antagonized the memory-facilitating effect of NE in the DG. We have demonstrated that MK801, at the dose chosen for interaction studies, did not markedly alter locomotor activity. These results together suggest that CRF, through a presynaptic facilitation mechanism, possibly facilitates NE release in the DG; increased NE release and stimulation of beta-adrenergic receptors in the DG result in NMDA receptor activations in the same area. This sequence of events enhance the memory consolidation process in the hippocampus and explained the neural mechanism of CRF in facilitating retention performance in rats. The same neuropeptide/neurotransmitter interactions may have other physiological and neuropathological implications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687386     DOI: 10.1002/syn.890140207

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  18 in total

1.  Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus.

Authors:  Y Chen; K L Brunson; M B Müller; W Cariaga; T Z Baram
Journal:  J Comp Neurol       Date:  2000-05-08       Impact factor: 3.215

2.  The effects of corticoliberin at different concentrations on long-term potentiation in slices of rat olfactory cortex.

Authors:  Ya E Lyubimov; N L Izvaidna; N A Emel'yanov; V N Chikhman; S D Solnushkin
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

3.  Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.

Authors:  Christopher M Stern; John Meitzen; Paul G Mermelstein
Journal:  Eur J Neurosci       Date:  2011-08-08       Impact factor: 3.386

4.  Hypothalamic corticotropin-releasing factor is centrally involved in learning under moderate stress.

Authors:  Morgan Lucas; Alon Chen; Gal Richter-Levin
Journal:  Neuropsychopharmacology       Date:  2013-04-08       Impact factor: 7.853

5.  Expression of integrin-associated protein gene associated with memory formation in rats.

Authors:  A M Huang; H L Wang; Y P Tang; E H Lee
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

6.  Impaired memory retention and decreased long-term potentiation in integrin-associated protein-deficient mice.

Authors:  H P Chang; F P Lindberg; H L Wang; A M Huang; E H Lee
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

7.  α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.

Authors:  Layla Azam; Uwe Maskos; Jean-Pierre Changeux; Cheryl D Dowell; Sean Christensen; Mariella De Biasi; J Michael McIntosh
Journal:  FASEB J       Date:  2010-08-25       Impact factor: 5.191

8.  Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I.

Authors:  Ward A Pedersen; Ruiqian Wan; Peisu Zhang; Mark P Mattson
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

9.  Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning.

Authors:  Thomas Blank; Ingrid Nijholt; Dimitris K Grammatopoulos; Harpal S Randeva; Edward W Hillhouse; Joachim Spiess
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

10.  Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation.

Authors:  Benno Roozendaal; Kristen L Brunson; Brian L Holloway; James L McGaugh; Tallie Z Baram
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.